Mankind Pharma Ltd Sees 12.03% Surge in Open Interest Amid Price Decline

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest today. The latest open interest stands at 15,126 contracts, reflecting a rise of 1,624 contracts or 12.03% from the previous open interest of 13,502. This surge in open interest comes alongside a trading volume of 12,948 contracts, indicating active participation in the market. Despite this uptick in open interest, Mankind Pharma's stock has underperformed relative to its sector, showing a decline of 1.62% today. The stock has faced consecutive losses over the past three days, with a total drop of 5.73% during this period. Today, it opened with a loss of 2.56%, reaching an intraday low of Rs 2,248.6, down 2.62%. In terms of liquidity, the stock remains accessible for trading, with a delivery volume of 312,000 shares on November 6, which is a 42.69% increase compared to the five-day average. Mankind Pharma is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, reflecting a challenging market position. Overall, the increase in open interest highlights a significant shift in market dynamics for Mankind Pharma, amidst a backdrop of declining stock performance.